Haodong Xu

4.8k citations
94 papers · 3.2k indexed · h-index 32
Topics
Machine Learning in Bioinformatics (12 papers)Neuroendocrine Tumor Research Advances (10 papers)RNA modifications and cancer (9 papers)

In The Last Decade

Haodong Xu

87 papers receiving 3.1k citations

Peers

Haodong Xu
Comparison fields: 5 of 127
  • Molecular Biology 2.2k
  • Cardiology and Cardiovascular Medicine 703
  • Oncology 389
  • Cancer Research 291
  • Cellular and Molecular Neuroscience 276
Replace Matthias Meier with:
Matthias Meier Germany
Xiaoping Wan China
Masato Maeda Japan
Hongqiang Cheng China
Benjamin J. Wilkins United States
John W. Fuseler United States
Jacques Bonnet France
Levent M. Akyürek Sweden
Steven J Brown United States
Mathias H. Konstandin Germany
Haodong Xu relative to Matthias Meier Germany Matthias Meier's profile →
Citations per field
00.5×1.5×2.5×
Matthias Meier · 1×
Citations per year

Countries citing papers authored by Haodong Xu

Since Specialization
Citations

This map shows the geographic impact of Haodong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haodong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haodong Xu more than expected).

Fields of papers citing papers by Haodong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haodong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haodong Xu. The network helps show where Haodong Xu may publish in the future.

Co-authorship network of co-authors of Haodong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Haodong Xu. A scholar is included among the top collaborators of Haodong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haodong Xu. Haodong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 5
3 0
4 1
5 0
6 0
7 17
8 5
9 32
10 2
11 3
12 34
13 17
14 22
15 10
16 18
17 43
18 17
19 83
20 73

About Haodong Xu

Haodong Xu is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 94 papers that have together received 3.2k indexed citations. Recurring topics across this work include Machine Learning in Bioinformatics (12 papers), Neuroendocrine Tumor Research Advances (10 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Cardiology and Cardiovascular Medicine (703 citations) and Cancer Research (291 citations). Haodong Xu has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Jeanne M. Nerbonne, Weinong Guo, Yu Xue, Wankun Deng, Shaofeng Lin, Jiaqi Zhou, Ying Zhang, Zhongming Zhao, Jian‐Ding Qiu and Shaoping Shi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026